23andMe Holding Co. - Common Stock (NQ:ME)

0.6063 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 23andMe Holding Co. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

20 Stocks Moving in Tuesday's Pre-Market Session ↗

June 14, 2022

Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 48.5% to $2.57 in pre-market trading after the company reached an agreement with Phillip Morris for international electronic nicotine...

Via Benzinga

Here's What Cramer Has To Say About Zuora, Johnson Controls International And More ↗

June 13, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Zuora Inc (NYSE: ZUO) is losing money. "It does not fit our criteria of what you should own," he added.

Via Benzinga

Cramer Says This Stock Is 'Way Too Speculative' ↗

April 04, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said 23andMe Holding Co. (NASDAQ: ME) is losing money. "To me, buy it and put it away," he commented.

Via Benzinga

These 5 SPACs All Plummeted After Celebrities Backed Them ↗

February 28, 2022

Attaching a celebrity's name to a SPAC is a good way to get people excited, but these SPACs all failed despite the support of some big names.

Via InvestorPlace

Earnings Scheduled For February 10, 2022 ↗

February 10, 2022

Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.

Via Benzinga

Earnings Scheduled For May 26, 2022 ↗

May 26, 2022

Companies Reporting Before The Bell • American Woodmark (NASDAQ:AMWD) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million.

Via Benzinga

Florida Credit Firm Leading Credit Repair Firm in all 50 states.

February 25, 2022

5 reasons why we are Rated #1 Credit Repair Firm in the United States. Helping Clients all over the 50 states fixing their credit.

Via IssueWire

7 Badly Bruised Stocks to Buy for the Tough-as-Nails Contrarian ↗

February 11, 2022

If you loathe groupthink in your investment decisions, these ideas could possibly suit you.

Via InvestorPlace

23andMe's Q3 Topline Beat Estimates On Boost From Telehealth Business Acquisition ↗

February 11, 2022

23andMe Holding Co (NASDAQ: ME) has updated its FY22 guidance following the inclusion of telehealth operations into its consumer business.

Via Benzinga

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly ↗

February 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

7 Penny Stocks With the Biggest Chance of Blasting Off This Year ↗

February 03, 2022

Penny stocks can rise quickly on relatively small catalysts, making them a great gamble. Here are a few that should rise.

Via InvestorPlace

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

Why Jim Cramer Like NextEra Energy And Lincoln Electric? ↗

January 21, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE:

Via Benzinga

23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock? ↗

January 18, 2022

Genetic testing company 23andMe Holding Co. (NASDAQ: ME) took the unconventional route of a SPAC deal to go public, and the stock hasn't gained much traction since it began...

Via Benzinga

7 of The Best SPAC Stocks to Put on Your 2022 Watchlist ↗

December 23, 2021

SPAC stocks may still be out of favor, but you'll still want to keep an eye on these seven picks with merger deals pending.

Via InvestorPlace

Like Strong Balance Sheets? These 3 Stocks Are Loaded With Cash ↗

December 10, 2021

With these kinds of resources, these companies are becoming less-risky investments.

Via The Motley Fool

Why 23andMe Stock Dropped 29% in November ↗

December 03, 2021

The company reported disappointing earnings results and has fallen victim to the recent sell-off in high-growth stocks.

Via The Motley Fool

Why 23andMe Stock Crashed 10% Today ↗

November 15, 2021

Last week's good news for the genetic data miner wasn't as good as it looked.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021 ↗

November 15, 2021

Upgrades For Targa Resources Corp (NYSE:

Via Benzinga

Why 23andMe Stock Scored an 11% Gain Today ↗

November 11, 2021

23andMe lost a lot less money than feared today -- so why is it sticking with a prediction for a full-sized loss for the year?

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 11, 2021

Gainers Liquidia (NASDAQ:LQDA) stock inc...

Via Benzinga

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

Kevin Durant Launching A SPAC That Could Target Sports Or Cryptocurrency ↗

November 03, 2021

One of the biggest National Basketball Association stars is dipping his toes into the SPAC market, becoming the latest celebrity or athlete to atta...

Via Benzinga

Why 23andMe Rocketed 27.9% Higher in October ↗

November 02, 2021

The genetics upstart is acquiring a telehealth platform.

Via The Motley Fool

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

November SPAC Merger Calendar: Upcoming Votes, Earnings, Stocks To Watch ↗

November 01, 2021

The month of November shows a continued slowdown in SPAC merger deal votes, but the calendar includes several multibillion-dollar deals. SPAC merger votes can act as a catalyst,...

Via Benzinga

These 3 Unique Stocks Have Undeniable Long-Term Upside ↗

October 29, 2021

These ideas are so unconventional that they just might work.

Via The Motley Fool

Why 23andMe Stock Was Up More Than 9% on Tuesday ↗

October 26, 2021

Investors may see potential in the company's proposed acquisition of telehealth company Lemonaid.

Via The Motley Fool

Why 23andMe Stock Dropped Today ↗

October 22, 2021

Fresh off its SPAC IPO, 23andMe is buying another company.

Via The Motley Fool

Topics Initial Public Offering

The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs ↗

October 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Athira Names Chief Operating Officer Mark Litton As Next CEO as Leen Kawas...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.